Biotech
Caris Life Sciences
Caris Life Sciences raises $168M Growth at $1.9B valuation
$168M
Total Raised
Growth
Latest Round
2018
Founded
1000+
Employees
Irving, TX
1 min read
Quick Facts
Valuation
$1.9B
Latest Round Size
$168M
Latest Round Date
October 2025
Caris Life Sciences: Growth Funding Round
Caris Life Sciences has successfully raised $168M in Growth funding, reaching a valuation of $1.9B.
Company Overview
Molecular profiling and AI/ML for precision medicine development
Funding Details
The Growth round was led by Braidwell.
Company Information
- Headquarters: Irving, TX
- Founded: 2018
- Employees: 1000+
- Category: Biotech
Investment
Caris Life Sciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Braidwell: Verified investor in Growth
Key Investors
Braidwell
Lead Investor
Verified investor in Growth
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Torl Biotherapeutics
Torl Biotherapeutics raises $96M Series C at $500M valuation
Torl Biotherapeutics raises $96M in Series C at $500M valuation. Antibody-based immunotherapies for cancer patients...
Editorial Team
Oct 10, 2025
1 min read•$96M
Biotech
Nilo Therapeutics
Nilo Therapeutics raises $101M Series A at $450M valuation
Nilo Therapeutics raises $101M in Series A at $450M valuation. Developing therapies based on neuro-immunology research...
Editorial Team
Oct 9, 2025
1 min read•$101M
Biotech
Arthrosi Therapeutics
Arthrosi Therapeutics raises $153M Series E at $800M valuation
Arthrosi Therapeutics raises $153M in Series E at $800M valuation. Developing next-generation gout treatment drug for chronic conditions...
Editorial Team
Oct 8, 2025
1 min read•$153M